Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Efaproxiral sodium

Base Information Edit
  • Chemical Name:Efaproxiral sodium
  • CAS No.:170787-99-2
  • Molecular Formula:C20H23NO4 . Na
  • Molecular Weight:363.38
  • Hs Code.:2924299090
  • European Community (EC) Number:811-228-2
  • UNII:3L83QP52XI
  • DSSTox Substance ID:DTXSID50168942
  • Wikidata:Q27257521
  • NCI Thesaurus Code:C72748
  • ChEMBL ID:CHEMBL2107744
  • Mol file:170787-99-2.mol
Efaproxiral sodium

Synonyms:Efaproxiral sodium;170787-99-2;RSR13 SODIUM;Sodium 2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoate;Efaproxiral (sodium);Efaproxiral Sodium;RSR 13 sodium;Efaproxiral sodium [USAN];UNII-3L83QP52XI;RSR-13 SODIUM;3L83QP52XI;170787-99-2 (sodium);Efaproxiral sodium (USAN);Sodium 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methylpropanoate;Propanoic acid, 2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methyl-, monosodium salt;sodium;2-[4-[2-(3,5-dimethylanilino)-2-oxoethyl]phenoxy]-2-methylpropanoate;2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid monosodium salt;Revaproxyn;2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxoethyl]phenoxy]-2-methylpropanoic acid monosodium salt;EFAPROXIRALSODIUM;Efaproxiral sodium [USAN];C20H23NO4.Na;SCHEMBL3763811;CHEMBL2107744;C20-H23-N-O4.Na;DTXSID50168942;HMS3652L04;EFAPROXIRAL SODIUM [MART.];BCP07458;EFAPROXIRAL SODIUM [WHO-DD];EX-A4942;HY-13619A;MFCD02093864;s4263;AKOS015896245;sodium 2-[4-[2-(3,5-dimethylanilino)-2-oxoethyl]phenoxy]-2-methylpropanoate;AC-5019;CCG-268204;CS-4949;AS-56984;E1356;FT-0658052;SW219343-1;A51048;D03962;A811239;Q27257521;2-(4((((3,5-Dimethylphenyl)amino)carbonyl)methyl)-phenoxy)-2-methyl propionic acid;2-(4-(((3,5-DIMETHYLANILINO)CARBONYL)METHYL)-PHENOXY)-2-METHYLPROPIONIC ACID SODIUM;SODIUM 2-(4-{[(3,5-DIMETHYLPHENYL)CARBAMOYL]METHYL}PHENOXY)-2-METHYLPROPANOATE;sodium,2-[4-[2-(3,5-dimethylanilino)-2-oxoethyl]phenoxy]-2-methylpropanoate;2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid monosodium salt;2-[4-[2-[(3,5-dimethylphenyl) amino]-2-oxoethyl]phenoxy]-2-methylpropanoic acid monosodium salt;sodium 2-[4-[2-[(3,5-dimethylphenyl)amino]-2-oxidanylidene-ethyl]phenoxy]-2-methyl-propanoate

Suppliers and Price of Efaproxiral sodium
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TCI Chemical
  • Efaproxiral Sodium
  • 250MG
  • $ 98.00
  • Matrix Scientific
  • Sodium 2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoate 95+%
  • 1g
  • $ 295.00
  • DC Chemicals
  • Efaproxiral Sodium >98%
  • 1 g
  • $ 1000.00
  • DC Chemicals
  • Efaproxiral Sodium >98%
  • 100 mg
  • $ 300.00
  • Crysdot
  • Efaproxiral Sodium 98+%
  • 50mg
  • $ 96.00
  • ChemScene
  • Efaproxiral Sodium 99.89%
  • 50mg
  • $ 84.00
  • Chem-Impex
  • Efaproxiralsodium,98%(Assay,HPLC) 98%(Assay,HPLC)
  • 250MG
  • $ 112.00
  • Biosynth Carbosynth
  • Efaproxiral sodium
  • 10 mg
  • $ 60.00
  • Biosynth Carbosynth
  • Efaproxiral sodium
  • 25 mg
  • $ 100.00
  • Biosynth Carbosynth
  • Efaproxiral sodium
  • 250 mg
  • $ 400.00
Total 45 raw suppliers
Chemical Property of Efaproxiral sodium Edit
Chemical Property:
  • Vapor Pressure:3.93E-13mmHg at 25°C 
  • Melting Point:240.0 ~244.0 °C 
  • Boiling Point:554.5 °C at 760 mmHg 
  • Flash Point:289.2 °C 
  • PSA:78.46000 
  • LogP:2.46490 
  • Solubility.:≥12.83 mg/mL in H2O with ultrasonic; ≥18.4 mg/mL in DMSO; ≥18.45 mg/mL in EtOH 
  • Hydrogen Bond Donor Count:1
  • Hydrogen Bond Acceptor Count:4
  • Rotatable Bond Count:6
  • Exact Mass:363.14465246
  • Heavy Atom Count:26
  • Complexity:464
Purity/Quality:

98%,99%, *data from raw suppliers

Efaproxiral Sodium *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)[O-])C.[Na+]
  • Recent EU Clinical Trials:A Phase 3 Randomized, Open-label Comparative Study of Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases from Breast Cancer
  • Uses Treatment of clinical conditions characterized by tissue hypoxia including cardiovascular, surgical, and critical care conditions; adjunctive treatment in standard radiation therapy and chemotherapy (synthetic allosteric modifier of hemoglobin.
Post RFQ for Price